A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Inclusion Criteria: * Age 18 years or older on date of enrollment * Confirmed by review of the date of birth as documented in the electronic medical record (EMR) and subsequently recorded in a case report form (CRF) * Diagnosed with stage I-III pancreatic cancer * Confirmed by EMR review. In cases where the EMR is unclear, their physician will be contacted and asked to confirm * Scheduled to receive neoadjuvant chemotherapy at Oregon Health \& Science University (OHSU) * Confirmed by EMR review. In cases where the EMR is unclear, their physician will be contacted and asked to confirm * Willing to adhere to the study protocol * Confirmed verbally with the participant and response documented in the Participant Tracking database Exclusion Criteria: * Cognitive difficulties that preclude answering the survey questions, participating in the intervention, or giving informed consent * In the event of a suspected undeclared cognitive impairment, it will be confirmed by physician clearance or professional opinion of the Principal Investigators, Dr. Kerri Winters-Stone and/or Dr. Jackilen Shannon * A medical condition, movement or neurological disorder, or medication use that contraindicates participation in light intensity exercise * Confirmed by a combination of reviewing the EMR, and self-report during the initial screening call. If in the professional opinion of the Principal Investigator, Dr. Kerri Winters-Stone or Dr. Jackilen Shannon, contraindications other than those identified by the patient or physician are present, she may consider the participant ineligible * Not fluent in English and therefore incapable of answer survey questions, reading the intervention web portal, and providing informed consent in English * Confirmed verbally with the participant and response documented in the Participant Tracking database